AI assistant
Inify Laboratories AB — AGM Information 2022
Jul 28, 2022
6123_rns_2022-07-28_49743d58-2753-4a0b-9a2c-8e0aef5f1d6f.html
AGM Information
Open in viewerOpens in your device viewer
Kallelse till extra bolagsstämma i Inify Laboratories AB (publ)
Kallelse till extra bolagsstämma i Inify Laboratories AB (publ)
STOCKHOLM - 28 juli, 2022 - Inify Laboratories AB (publ) kallar härmed sina
aktieägare till en extra bolagsstämma den 30:e augusti 2022. Bifogat finns
kallelse inklusive dagordning och instruktioner för registrering och röstning.
Vänligen kontakta bolagets CFO Ann-Charlotte Linderoth på e-post: ann
[email protected] för frågor gällande den extra bolagsstämman.
Inify Laboratories provides cancer diagnostics through ultra-modern laboratory
services within histopathology. Fully digital, standardized and AI- supported
workflow is applied to optimize quality and response times, initially for
prostate cancer. The concept is scalable and extendible to other diagnosis. The
company origins from ContextVision and became independent in February 2022. The
company is based in Sweden and listed on Euronext Growth Oslo under the ticker
INIFY.